Zydus gets final approval from US FDA for Type 2 diabetes pills
Ahmedabad, July 19 (IANS) Indian pharma company Zydus Lifesciences on Friday said that it has received final approval from the US Food and Drug Administration (USFDA) to market tablets for Type 2 diabetes. The drugmaker said it got “approval for its New Drug Application (NDA) to market Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets”.
Ahmedabad, July 19 (IANS) Indian pharma company Zydus Lifesciences on Friday said that it has received final approval from the US Food and Drug Administration (USFDA) to market tablets for Type 2 diabetes.
The drugmaker said it got “approval for its New Drug Application (NDA) to market Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets”.
With this, Zydus has all three NDAs of Sitagliptin (base) and combination franchise approved, it added.
“Notably, all the three NDAs achieved first-cycle approval (FCA),” the company stated.
Further, it added that the product will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ, India.
According to IQVIA (MAT May 2024), the US market for DPP-IV inhibitors and its combinations is $9.5 bn.
–IANS
rvt/rad
ଖଟଶେଜ ଘରକୁ ସ୍ଥାନାନ୍ତର ହେଲା ଭିତର ରତ୍ନଭଣ୍ଡାର ଅଳଙ୍କାର
Next Articleଗୀତା ଉପଦେଶ: ଆତ୍ମଶୁଦ୍ଧି ପାଇଁ ତପସ୍ୟା ଏକ ଶକ୍ତିଶାଳୀ ମାଧ୍ୟମ
Related Articles
Health & LifestyleStudy decodes why promising cancer treatments trigger serious side effects
New Delhi: While cancer has seen some significant advancements in treatments that have shown promise and increased lifespan, however, it also causes serious side effects, which can affect quality of life. A new study by researchers from Australia is shedding new light on the reasons behind these side effects, Xinhua news agency reported. The team
Covid hospitalisation, family history, lifestyle behaviours behind unexplained sudden death: ICMR study
Health & LifestyleCovid hospitalisation, family history, lifestyle behaviours behind unexplained sudden death: ICMR study
New Delhi: Hospitalisations due to severe Covid-19 infection, a family history of sudden deaths, as well as lifestyle behaviours are some of the reasons behind the unexplained sudden death, according to a study led by the Indian Council of Medical Research (ICMR). The peer-reviewed study published in the Indian Journal of Medical Research explored factors
ICMR, AIIMS studies found no link between Covid vaccine & sudden deaths: Centre
Health & LifestyleICMR, AIIMS studies found no link between Covid vaccine & sudden deaths: Centre
New Delhi: Extensive studies undertaken by the Indian Council of Medical Research (ICMR), and All India Institute of Medical Sciences (AIIMS) have conclusively established no link between Covid-19 vaccines and sudden deaths, the Ministry of Health and Family Welfare said on Wednesday. Post the Covid pandemic several cases of heart attack-related death among people, especially